Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

Market Cap	3.18B -12.9%
Revenue (ttm)	4.45B +21.9%
Net Income	416.30M +7.9%
EPS	20.98 +3.3%
Shares Out	19.00M
PE Ratio	7.98
Forward PE	n/a
Dividend	2.00 (1.19%)
Ex-Dividend Date	Aug 14, 2025

Volume	15,907
Open	167.90
Previous Close	167.32
Day's Range	167.11 - 171.44
52-Week Range	126.15 - 238.69
Beta	0.82
Analysts	Strong Buy
Price Target	n/a
Earnings Date	Jul 31, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; plant nutrient supplements; pearl millets; seeds for field crops, such as bajra, maize, corn, paddy, wheat, and jowar; and seeds for vegetables comprising chilli, okra, tomato, bitter gourd, and cucumber. It also provides crop protection supplements under the Win-ch...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1979
• Employees: 451
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NATHBIOGEN

Financial Performance

In fiscal year 2026, Nath Bio-Genes (India)'s revenue was 4.45 billion, an increase of 21.93% compared to the previous year's 3.65 billion. Earnings were 416.30 million, an increase of 7.85%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 18, 2026

Data Sources Report a data error